Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CETAGESIC TABLET - HSA Drug Approval Details

Approvals/HSA/CETAGESIC TABLET

Approved

THERAPEUTIC

CETAGESIC TABLET

DUOPHARMA (M) SDN BHD (MALAYSIA)🇸🇬 Health Sciences Authority

Approval Date: Apr 22, 1991
Approval ID: f35f8efd1a8c5c9b
Company: DUOPHARMA (M) SDN BHD (MALAYSIA)
Type: Therapeutic

Approval Details

Approval Id: f35f8efd1a8c5c9b
Drug Name: CETAGESIC TABLET
Product Name: CETAGESIC TABLET
Approval Number: SIN05771P
Approval Date: 1991-04-22
Registrant: DUOPHARMA (SINGAPORE) PTE LTD
Licence Holder: DUOPHARMA (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: M03BC51
Atc Item Name: orphenadrine, combinations
Pharma Manufacturer Name: DUOPHARMA (SINGAPORE) PTE. LTD.
Company Detail Path: /organization/duopharma-singapore-pte-ltd

Active Ingredients

PARACETAMOL

500 mg

ORPHENADRINE CITRATE

25 mg

ORPHENADRINE CITRATE

25 MG

PARACETAMOL

500 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Apr 22, 1991

Approval ID

f35f8efd1a8c5c9b

Type

Therapeutic

Back to HSA Approvals